APA (7th ed.) Citation

Skolariki, A., D’Costa, J., Little, M., & Lord, S. (2022). Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: Concept to clinic. Exploration of targeted anti-tumor therapy, 3(2), 172-199. https://doi.org/10.37349/etat.2022.00078

Chicago Style (17th ed.) Citation

Skolariki, Aglaia, Jamie D’Costa, Martin Little, and Simon Lord. "Role of PI3K/Akt/mTOR Pathway in Mediating Endocrine Resistance: Concept to Clinic." Exploration of Targeted Anti-tumor Therapy 3, no. 2 (2022): 172-199. https://doi.org/10.37349/etat.2022.00078.

MLA (9th ed.) Citation

Skolariki, Aglaia, et al. "Role of PI3K/Akt/mTOR Pathway in Mediating Endocrine Resistance: Concept to Clinic." Exploration of Targeted Anti-tumor Therapy, vol. 3, no. 2, 2022, pp. 172-199, https://doi.org/10.37349/etat.2022.00078.